CS logo
small CS logo
Klinikum rechts der Isar der TU München; Urologische Klinik und Poliklinik

Munchen, Germany

About Klinikum rechts der Isar der TU München; Urologische Klinik und Poliklinik


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Klinikum rechts der Isar der TU München; Urologische Klinik und Poliklinik


During the past decade, Klinikum rechts der Isar der TU München; Urologische Klinik und Poliklinik conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum rechts der Isar der TU München; Urologische Klinik und Poliklinik" #1 collaborator was "Chugai" with 1 trials as a collaborator and "Exelixis" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at Klinikum rechts der Isar der TU München; Urologische Klinik und Poliklinik


According to Clinical.Site data, the most researched conditions in "Klinikum rechts der Isar der TU München; Urologische Klinik und Poliklinik" are "Bladder Cancer" (3 trials), "Carcinoma, Renal Cell" (1 trials), "Carcinoma, Transitional Cell" (1 trials), "Hormonal Refractory Prostate Cancer" (1 trials) and "Muscle-invasive Bladder Cancer" (1 trials). Many other conditions were trialed in "Klinikum rechts der Isar der TU München; Urologische Klinik und Poliklinik" in a lesser frequency.

Clinical Trials Intervention Types at Klinikum rechts der Isar der TU München; Urologische Klinik und Poliklinik


Most popular intervention types in "Klinikum rechts der Isar der TU München; Urologische Klinik und Poliklinik" are "Drug" (8 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (7 trials), "Placebo" (2 trials), "Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody" (1 trials), "CV9103" (1 trials) and "Cabozantinib" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Klinikum rechts der Isar der TU München; Urologische Klinik und Poliklinik


The vast majority of trials in "Klinikum rechts der Isar der TU München; Urologische Klinik und Poliklinik" are 8 trials for "All" genders and 1 trials for "Male" genders.

Clinical Trials Status at Klinikum rechts der Isar der TU München; Urologische Klinik und Poliklinik


Currently, there are NaN active trials in "Klinikum rechts der Isar der TU München; Urologische Klinik und Poliklinik". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Klinikum rechts der Isar der TU München; Urologische Klinik und Poliklinik, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum rechts der Isar der TU München; Urologische Klinik und Poliklinik, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".